Actovegin vs Ghrelinomimetic
Overview
Actovegin is primarily a pain management peptide, while Ghrelinomimetic is used for healing & recovery.
This page compares Actovegin and Ghrelinomimetic across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Actovegin | Ghrelinomimetic | |
|---|---|---|
| Category | Pain Management | Healing & Recovery |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 5-10 ml | 100-200 mcg |
| Frequency | multiple weekly | daily |
| Reported benefits | Circulation-related pain relief, tissue oxygenation, healing support | Increased appetite, gut healing, muscle preservation |
| Reported side effects | Rare allergic reactions | Increased hunger, water retention |
Key differences
Primary use. Actovegin is categorised under Pain Management, while Ghrelinomimetic falls under Healing & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Actovegin: not FDA-approved; treated as a research compound. Ghrelinomimetic: not FDA-approved; treated as a research compound.
Dosing. Actovegin is typically dosed at 5-10 ml (multiple weekly). Ghrelinomimetic is typically dosed at 100-200 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Actovegin and Ghrelinomimetic has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Actovegin and Ghrelinomimetic?
- Actovegin is primarily a pain management peptide, while Ghrelinomimetic is used for healing & recovery. Actovegin is not FDA-approved; generally classified as a research compound, whereas Ghrelinomimetic is not FDA-approved; generally classified as a research compound.
- What is Actovegin used for?
- Hypoxic pain and healing.
- What is Ghrelinomimetic used for?
- Appetite and healing support.
- Can you take Actovegin and Ghrelinomimetic together?
- Some users combine peptides within a single protocol, but stacking Actovegin and Ghrelinomimetic has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Actovegin or Ghrelinomimetic FDA-approved?
- Actovegin is not FDA-approved; generally classified as a research compound. Ghrelinomimetic is not FDA-approved; generally classified as a research compound.
Read the full articles
- Actovegin — full monograph: mechanism, research, dosing & references
- Ghrelinomimetic — full monograph: mechanism, research, dosing & references